|
Lani or others following the SABCS Posters
To anyone reviewing the posters for the upcoming SABCS Conference - or anyone else in the know,
I've been looking for a poster for the results of the Phase III GSK Clinical Trial involving combining Herceptin and Lapatinib (EGF104900). It doesn't appear to be on the schedule.
Just thought I'd throw this out there in case anyone has an inside source.
With warm regards,
Amy
__________________
Amy age 37 at dx
Feb 2008 Multifocal DCIS
Apr 2008 Bilateral Mastectomies
Sister to Laura age 37 at dx
April 2006
9 cm ER-/PR- Her2 +++/bone mets
neoadjuvant TCH plus Zometa
November 2006
bilateral mastectomy - Change to ER+/PR- Her2 +++
January 2007
innumerable tiny brain mets - WBR
March 2007
good response to WBR - some gone, all smaller
currently on Lapatinib and Xeloda
Feb 2008
Brain MRI: brain mets went from innumerable (jan '07) to 5 (june '07) to 3 (oct '07) to 1 that is getting less conspicuous(feb '08) PET/CT: Slight uptake in some sclerotic bone mets
|